BackSolasia Pharma K.K. Overview

Solasia Pharma K.K. Receivables

Solasia Pharma K.K.'s receivables is $22M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$22.00M
↓ 15.38% YoYΔ $-4.00M vs prior year quarter

Peer trimmed avg / median

Loading

Solasia Pharma K.K. Receivables History

Loading

Solasia Pharma K.K. vs. peers: Receivables Comparison

Loading

Solasia Pharma K.K. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Solasia Pharma K.K. (4597.T) FAQ

As of the most recent data (June 2026), 4597.T shows a receivables of $22M. That compares with $26M in the prior-year period — down 15.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4597.T's receivables is now $22M (was $26M) — a 15.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Solasia Pharma K.K. is outperforming or lagging.

Tracking 4597.T's receivables over time shows whether Solasia Pharma K.K. is scaling, shrinking, or reshaping that part of the business. The current reading is $22M That compares with $26M in the prior-year period — down 15.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Solasia Pharma K.K.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $22M) with ownership activity and broader fundamentals.